Inspire Medical Systems

INSP on NYSE. Inspire Medical Systems sells nerve stimulators that treat sleep apnea in patients. Market value $2.0bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.

We can't read total debt from the filing, so debt is left out.

Should I look at this?

Not a fit for our list right now

See Health care stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
5.9%fair

For every $100 of what the whole company costs, it produced $5.94 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
n/a

The filings do not give us enough to work this out.

Return on capital
five annual reports to December 2025
n/a

The filings do not give us enough to work this out.

Quality score: 56 of 100. Price score: 82 of 100. Our list needs 70 on quality and 60 on price.

$68.20 a share, 75% above its 1-year low

Over the past year the price has ranged from $38.91 to $147.03.

Pays no dividend

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

-0.0
0.0
0.0
0.1
0.1
0.1
2021202220232024202512 monthsto Jun '26

Spare cash swings from quarter to quarter here: $117 million in the past 12 months, $78 million in the year to December 2025.

Revenue
$233m$408m$625m$803m$912m
Operating margin
-17.1%-11.7%-6.4%4.5%5.6%
Debt to equity
0.11n/an/an/an/a
Shares outstanding
0.03bn0.03bn0.03bn0.03bn0.03bn

Health checks

  • Free cash flow positive4 of 5 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)6 of 8 checks we could run
  • Profit backed by cash (accruals)Yes
  • DebtUnknown
  • Revenue growth, five yearsStrong, 51.2% a year
  • Buying back its own sharesRoughly flat

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $201 million last quarter, down 8% on a year ago.
  • Profit: $314,000, after a loss of $4 million a year ago.
  • It keeps 6 cents of each $1 of sales as operating profit, up from 5 cents a year earlier.
  • Spare cash over the past 12 months: $117 million, up from $85 million.
  • 2% fewer shares than a year ago. Each share owns a bit more of the company.
  • Sales grew on a year ago in 3 of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$203m
December 2024$240m
March 2025$201m
June 2025$217m
September 2025$225m
December 2025$269m
March 2026$205m
June 2026$201m
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$18m
December 2024$35m
March 2025$3m
June 2025-$4m
September 2025$10m
December 2025$136m
March 2026-$11m
June 2026$314,000

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
13 February 2026
Next quarterly (estimated, 10-Q)
2 November 2026

Who owns it

2 long-term investors we follow own it, unchanged from 2 last quarter. 275 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

10 investors own more than 5%.

  • BlackRock, Inc.
    Passive investor
    14.4%+3.1 pts
    Since 30 June 2026
  • at least 8.8%+1.2 pts
    (filed with 3 related holders)
    Since 31 March 2026
  • 7.4%+1.7 pts
    Since 30 June 2026
  • Soleus Capital Master Fund, L.P.
    Passive investor
    at least 6.7%+1.6 pts
    (filed with 5 related holders)
    Since 30 June 2026
  • at least 6.4%
    (filed with 1 related holder)
    Since 30 June 2026
  • D. E. Shaw & Co., L.P.
    Passive investor
    at least 5.1%
    (filed with 1 related holder)
    Since 25 June 2026
  • 5.1%
    Since 31 March 2026
  • Deerfield Mgmt, L.P.
    Passive investor
    at least 4.5%−0.6 pts
    (filed with 3 related holders)
    Since 14 May 2026
  • FMR LLC
    Passive investor
    at least 2.5%−5.8 pts
    (filed with 1 related holder)
    Since 30 September 2025
  • Kenneth Griffin
    Passive investor
    at least 1.8%−4.0 pts
    (filed with 6 related holders)
    Since 31 December 2025
  • Wasatch Advisors LP
    Passive investor
    Sold down below 5%
    Since 30 September 2025
  • The Vanguard Group
    Passive investor
    Sold down below 5%
    Since 13 March 2026
  • Sold down below 5%
    Since 30 September 2025

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 3 sold $665,952, $464,196 of it under preset trading plans.

  • Kelly Jason P
    See Remarks
    Sold
    Date
    7 August 2026
    Shares
    963
    Price
    $59.55
    Value
    $57,347
  • Rondoni John
    See Remarks
    Sold
    Date
    15 May 2026
    Shares
    2,641
    Price
    $43.28
    Value
    $114,302
  • Rondoni John
    See Remarks
    Sold
    Date
    14 May 2026
    Shares
    700
    Price
    $43.01
    Value
    $30,107
  • mcCormick Shawn
    Director
    Sold
    under a preset trading plan
    Date
    8 May 2026
    Shares
    696
    Price
    $45.31
    Value
    $31,536
  • Rondoni John
    See Remarks
    Sold
    under a preset trading plan
    Date
    9 January 2026
    Shares
    109
    Price
    $100.00
    Value
    $10,900
  • mcCormick Shawn
    Director
    Sold
    under a preset trading plan
    Date
    2 December 2025
    Shares
    1,200
    Price
    $139.00
    Value
    $166,800
  • mcCormick Shawn
    Director
    Sold
    under a preset trading plan
    Date
    28 November 2025
    Shares
    2,000
    Price
    $127.48
    Value
    $254,960

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 13 Feb 2026, plus the 10-Q filed 3 Aug 2026 and 6 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.